Crohn’s Disease Market By Procedure and Drug - Global Industry Analysis And Forecast To 2027
Published On : December 2018 Pages : 150 Category: Pharma & Healthcare Report Code : HC122199
Crohn’s Disease Market By Procedure (Magnetic Resonance Imaging (MRI), Double-Balloon Endoscope, Computerized Tomography (CT), Colonoscopy, Small Bowel Imaging, Flexible Sigmoidoscopy and Capsule Endoscopy) and Drug (Anti-Inflammatory Drugs, Pain Relievers, Antibiotics, Immune System Suppressors and Anti-Diarrheal) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Crohn’s disease is a Crohn’sic inflammatory bowel disease (IBD), symptoms showing inflammation of digestive or gastrointestinal tract. Crohn’s disease affects the gastrointestinal tract, i.e. from the mouth to anus, but mainly found at the end of small intestine where it joins large intestine. Eyes, skin and joints are also affected by Crohn’s disease. Exact reason behind Crohn’s disease is unknown, if it is Crohn’s or ongoing. Symptoms of the disesase differ from part to part as the whole gastrointestinal tract is affected. There is treatment available for Crohn’s disease in the form of medication or surgery, treatment depends on the symptoms. Therefore, the Crohn’s Disease Market is anticipated to expand and has tremendous scope during the forecast period. The global Crohn’s Disease Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Crohn’s Disease Market is based on segment, by Procedure the market is segmented into Magnetic Resonance Imaging (MRI), Double-Balloon Endoscope, Computerized Tomography (CT ), Colonoscopy, Small Bowel Imaging, Flexible Sigmoidoscopy and Capsule Endoscopy; and by Drug the market is segmented into Anti-Inflammatory Drugs, Pain Relievers, Antibiotics, Immune System Suppressors and Anti-Diarrheal.
- Crohn’s Disease Market, By Procedure
- Magnetic Resonance Imaging (MRI)
- Double-Balloon Endoscope
- Computerized Tomography (CT )
- Colonoscopy
- Small Bowel Imaging
- Flexible Sigmoidoscopy
- Capsule Endoscopy
- Crohn’s Disease Market, By Drug
- Anti-Inflammatory Drugs
- Pain Relievers
- Antibiotics
- Immune System Suppressors
- Anti-Diarrheal
Regional Insights
On a global front, the Crohn’s Disease Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).
Crohn’s Disease Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Ferring B.V., Johnson & Johnson Services Inc., Allergan, Inc., Perrigo Company plc. AbbVie Inc., Pfizer Inc., UCB S.A., Takeda Pharmaceutical Company Limited and Bayer AG. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Ferring B.V.
- Johnson & Johnson Services Inc.
- Allergan, Inc.
- Perrigo Company plc.
- AbbVie Inc.
- Pfizer Inc.
- UCB S.A.
- Takeda Pharmaceutical Company Limited
- Bayer AG
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Crohn Disease Market, By Procedure, Estimates and Forecast, 2017-2027 ($Million)
o Magnetic Resonance Imaging (MRI)
o Double-Balloon Endoscope
o Computerized Tomography (CT )
o Colonoscopy
o Small Bowel Imaging
o Flexible Sigmoidoscopy
o Capsule Endoscopy
o Crohn Disease Market, By Drug, Estimates and Forecast, 2017-2027 ($Million)
o Anti-Inflammatory Drugs
o Pain Relievers
o Antibiotics
o Immune System Suppressors
o Anti-Diarrheal
o Crohn Disease Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Crohn Disease Market, By Country
o U.S. Crohn Disease Market
o Canada Crohn Disease Market
o Mexico Crohn Disease Market
o Europe
§ Europe Crohn Disease Market, By Country
o Germany Crohn Disease Market
o UK Crohn Disease Market
o France Crohn Disease Market
o Russia Crohn Disease Market
o Italy Crohn Disease Market
o Rest of Europe Crohn Disease Market
o Asia-Pacific
§ Asia-Pacific Crohn Disease Market, By Country
o China Crohn Disease Market
o Japan Crohn Disease Market
o South Korea Crohn Disease Market
o India Crohn Disease Market
o Southeast Asia Crohn Disease Market
o Rest of Asia-Pacific Crohn Disease Market
o South America
§ South America Crohn Disease Market, By Country
o Brazil Crohn Disease Market
o Argentina Crohn Disease Market
o Columbia Crohn Disease Market
o Rest of South America Crohn Disease Market
o Middle East and Africa
§ Middle East and Africa Crohn Disease Market, By Country
o Saudi Arabia Crohn Disease Market
o UAE Crohn Disease Market
o Egypt Crohn Disease Market
o Nigeria Crohn Disease Market
o South Africa Crohn Disease Market
o Rest of MEA Crohn Disease Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Crohn’s Disease Market, By Procedure
5.1. Introduction
5.2. Global Crohn’s Disease Revenue and Market Share by Procedure (2017-2027)
5.2.1. Global Crohn’s Disease Revenue and Revenue Share by Procedure (2017-2027)
5.3. Magnetic Resonance Imaging (MRI)
5.3.1. Global Magnetic Resonance Imaging (MRI) Revenue and Growth Rate (2017-2027)
5.4. Double-Balloon Endoscope
5.4.1. Global Double-Balloon Endoscope Revenue and Growth Rate (2017-2027)
5.5. Computerized Tomography (CT)
5.5.1. Global Computerized Tomography (CT) Revenue and Growth Rate (2017-2027)
5.6. Colonoscopy
5.6.1. Global Colonoscopy Revenue and Growth Rate (2017-2027)
5.7. Small Bowel Imaging
5.7.1. Global Small Bowel Imaging Revenue and Growth Rate (2017-2027)
5.8. Flexible Sigmoidoscopy
5.8.1. Global Flexible Sigmoidoscopy Revenue and Growth Rate (2017-2027)
5.9. Capsule Endoscopy
5.9.1. Global Capsule Endoscopy Revenue and Growth Rate (2017-2027)
6. Crohn’s Disease Market, By Drug
6.1. Introduction
6.2. Global Crohn’s Disease Revenue and Market Share by Drug (2017-2027)
6.2.1. Global Crohn’s Disease Revenue and Revenue Share by Drug (2017-2027)
6.3. Anti-Inflammatory Drugs
6.3.1. Global Anti-Inflammatory Drugs Revenue and Growth Rate (2017-2027)
6.4. Pain Relievers
6.4.1. Global Pain Relievers Revenue and Growth Rate (2017-2027)
6.5. Antibiotics
6.5.1. Global Antibiotics Revenue and Growth Rate (2017-2027)
6.6. Immune System Suppressors
6.6.1. Global Immune System Suppressors Revenue and Growth Rate (2017-2027)
6.7. Anti-Diarrheal
6.7.1. Global Anti-Diarrheal Revenue and Growth Rate (2017-2027)
7. Crohn’s Disease Market, By Region
7.1. Introduction
7.2. Global Crohn’s Disease Revenue and Market Share by Regions
7.2.1. Global Crohn’s Disease Revenue by Regions (2017-2027)
7.3. North America Crohn’s Disease by Countries
7.3.1. North America Crohn’s Disease Revenue and Growth Rate (2017-2027)
7.3.2. North America Crohn’s Disease Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Crohn’s Disease by Countries
7.4.1. Europe Crohn’s Disease Revenue and Growth Rate (2017-2027)
7.4.2. Europe Crohn’s Disease Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Crohn’s Disease by Countries
7.5.1. Asia-Pacific Crohn’s Disease Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Crohn’s Disease Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Crohn’s Disease by Countries
7.6.1. South America Crohn’s Disease Revenue and Growth Rate (2017-2027)
7.6.2. South America Crohn’s Disease Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Crohn’s Disease by Countries
7.7.1. Middle East and Africa Crohn’s Disease Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Crohn’s Disease Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Ferring B.V.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. Johnson & Johnson Services Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. Allergan, Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Perrigo Company plc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. AbbVie Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Pfizer Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. UCB S.A.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
8.8. Takeda Pharmaceutical Company Limited
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Revenue and Market Share
8.9. Bayer AG
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Revenue and Market Share
9. Global Crohn’s Disease Market Competition, by Manufacturer
9.1. Global Crohn’s Disease Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Crohn’s Disease Price By Region (2017-2017)
9.3. Top 5 Crohn’s Disease Manufacturer Market Share
9.4. Market Competition Trend
10. Crohn’s Disease Market Forecast (2017-2027)
10.1. Global Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Crohn’s Disease Market Forecast by Regions (2017-2027)
10.2.1. North America Crohn’s Disease Market Forecast (2017-2027)
10.2.1.1. United States Crohn’s Disease Market Forecast (2017-2027)
10.2.1.2. Canada Crohn’s Disease Market Forecast (2017-2027)
10.2.1.3. Mexico Crohn’s Disease Market Forecast (2017-2027)
10.2.2. Europe Crohn’s Disease Market Forecast (2017-2027)
10.2.2.1. Germany Crohn’s Disease Market Forecast (2017-2027)
10.2.2.2. France Crohn’s Disease Market Forecast (2017-2027)
10.2.2.3. UK Crohn’s Disease Market Forecast (2017-2027)
10.2.2.4. Russia Crohn’s Disease Market Forecast (2017-2027)
10.2.2.5. Italy Crohn’s Disease Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Crohn’s Disease Market Forecast (2017-2027)
10.2.3. Asia-Pacific Crohn’s Disease Market Forecast (2017-2027)
10.2.3.1. China Crohn’s Disease Market Forecast (2017-2027)
10.2.3.2. Japan Crohn’s Disease Market Forecast (2017-2027)
10.2.3.3. Korea Crohn’s Disease Market Forecast (2017-2027)
10.2.3.4. India Crohn’s Disease Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Crohn’s Disease Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Crohn’s Disease Market Forecast (2017-2027)
10.2.4. South America Crohn’s Disease Market Forecast (2017-2027)
10.2.4.1. Brazil Crohn’s Disease Market Forecast (2017-2027)
10.2.4.2. Argentina Crohn’s Disease Market Forecast (2017-2027)
10.2.4.3. Columbia Crohn’s Disease Market Forecast (2017-2027)
10.2.4.4. Rest of South America Crohn’s Disease Market Forecast (2017-2027)
10.2.5. Middle East and Africa Crohn’s Disease Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Crohn’s Disease Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Crohn’s Disease Market Forecast (2017-2027)
10.2.5.3. Egypt Crohn’s Disease Market Forecast (2017-2027)
10.2.5.4. Nigeria Crohn’s Disease Market Forecast (2017-2027)
10.2.5.5. South Africa Crohn’s Disease Market Forecast (2017-2027)
10.2.5.6. Turkey Crohn’s Disease Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Crohn’s Disease Market Forecast (2017-2027)
10.3. Crohn’s Disease Market Forecast by Procedure (2017-2027)
10.3.1. Crohn’s Disease Forecast by Procedure (2017-2027)
10.3.2. Crohn’s Disease Market Share Forecast by Procedure (2017-2027)
10.4. Crohn’s Disease Market Forecast by Drug (2017-2027)
10.4.1. Crohn’s Disease Forecast by Drug (2017-2027)
10.4.2. Crohn’s Disease Market Share Forecast by Drug (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Crohn’s Disease Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Crohn’s Disease Revenue and Revenue Share by Procedure (2017-2018)
Figure Global Magnetic Resonance Imaging (MRI) Revenue and Growth Rate (2017-2018)
Figure Global Double-Balloon Endoscope Revenue and Growth Rate (2017-2018)
Figure Global Computerized Tomography (CT) Revenue and Growth Rate (2017-2018)
Figure Global Colonoscopy Revenue and Growth Rate (2017-2018)
Figure Global Small Bowel Imaging Revenue and Growth Rate (2017-2018)
Figure Global Flexible Sigmoidoscopy Revenue and Growth Rate (2017-2018)
Figure Global Capsule Endoscopy Revenue and Growth Rate (2017-2018)
Table Global Crohn’s Disease Revenue and Revenue Share by Drug (2017-2018)
Figure Global Anti-Inflammatory Drugs Revenue and Growth Rate (2017-2018)
Figure Global Pain Relievers Revenue and Growth Rate (2017-2018)
Figure Global Antibiotics Revenue and Growth Rate (2017-2018)
Figure Global Immune System Suppressors Revenue and Growth Rate (2017-2018)
Figure Global Anti-Diarrheal Revenue and Growth Rate (2017-2018)
Table Global Crohn’s Disease Revenue by Regions (2017-2018)
Figure North America Crohn’s Disease Growth Rate (2017-2018)
Figure North America Crohn’s Disease Revenue and Growth Rate (2017-2018)
Figure North America Crohn’s Disease by Countries (2017-2018)
Figure North America Crohn’s Disease Revenue (Million USD) by Countries (2017-2018)
Figure United States Crohn’s Disease Growth Rate (2017-2018)
Figure United States Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Crohn’s Disease Growth Rate (2017-2018)
Figure Canada Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Crohn’s Disease Growth Rate (2017-2018)
Figure Mexico Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Crohn’s Disease Growth Rate (2017-2018)
Figure Europe Crohn’s Disease Revenue and Growth Rate (2017-2018)
Figure Europe Crohn’s Disease by Countries (2017-2018)
Figure Europe Crohn’s Disease Revenue (Million USD) by Countries (2017-2018)
Figure Germany Crohn’s Disease Growth Rate (2017-2018)
Figure Germany Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Crohn’s Disease Growth Rate (2017-2018)
Figure France Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Crohn’s Disease Growth Rate (2017-2018)
Figure UK Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Crohn’s Disease Growth Rate (2017-2018)
Figure Russia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Crohn’s Disease Growth Rate (2017-2018)
Figure Italy Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Crohn’s Disease Growth Rate (2017-2018)
Figure Rest of Europe Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Crohn’s Disease Growth Rate (2017-2018)
Figure Asia-Pacific Crohn’s Disease Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Crohn’s Disease by Countries (2017-2018)
Figure Asia-Pacific Crohn’s Disease Revenue (Million USD) by Countries (2017-2018)
Figure China Crohn’s Disease Growth Rate (2017-2018)
Figure China Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Crohn’s Disease Growth Rate (2017-2018)
Figure Japan Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Crohn’s Disease Growth Rate (2017-2018)
Figure Korea Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Crohn’s Disease Growth Rate (2017-2018)
Figure India Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Crohn’s Disease Growth Rate (2017-2018)
Figure Southeast Asia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Crohn’s Disease Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Crohn’s Disease Growth Rate (2017-2018)
Figure South America Crohn’s Disease Revenue and Growth Rate (2017-2018)
Figure South America Crohn’s Disease by Countries (2017-2018)
Figure South America Crohn’s Disease Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Crohn’s Disease Growth Rate (2017-2018)
Figure Brazil Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Crohn’s Disease Growth Rate (2017-2018)
Figure Argentina Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Crohn’s Disease Growth Rate (2017-2018)
Figure Columbia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Crohn’s Disease Growth Rate (2017-2018)
Figure Rest of South America Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Crohn’s Disease Growth Rate (2017-2018)
Figure Middle East and Africa Crohn’s Disease Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Crohn’s Disease by Countries (2017-2018)
Figure Middle East and Africa Crohn’s Disease Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Crohn’s Disease Growth Rate (2017-2018)
Figure Saudi Arabia Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Crohn’s Disease Growth Rate (2017-2018)
Figure United Arab Emirates Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Crohn’s Disease Growth Rate (2017-2018)
Figure Egypt Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Crohn’s Disease Growth Rate (2017-2018)
Figure Nigeria Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Crohn’s Disease Growth Rate (2017-2018)
Figure South Africa Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Crohn’s Disease Growth Rate (2017-2018)
Figure Turkey Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Crohn’s Disease Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Crohn’s Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Table Ferring B.V. Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Johnson & Johnson Services Inc. Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Allergan, Inc. Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Perrigo Company plc. Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AbbVie Inc. Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table UCB S.A. Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Takeda Pharmaceutical Company Limited Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer AG Crohn’s Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Crohn’s Disease Market Share by Manufacturer
Figure Global Crohn’s Disease Revenue and Market Share by Manufacturer
Table Global Crohn’s Disease Price by Region (2017-2017)
Figure Top 5 Crohn’s Disease Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Crohn’s Disease Revenue (Millions USD) and Growth Rate (2018-2025)
Table Crohn’s Disease Market Forecast by Regions (2018-2025)
Figure North America Crohn’s Disease Market Forecast (2018-2025)
Figure United States Crohn’s Disease Market Forecast (2018-2025)
Figure Canada Crohn’s Disease Market Forecast (2018-2025)
Figure Mexico Crohn’s Disease Market Forecast (2018-2025)
Figure Europe Crohn’s Disease Market Forecast (2018-2025)
Figure Germany Crohn’s Disease Market Forecast (2018-2025)
Figure France Crohn’s Disease Market Forecast (2018-2025)
Figure UK Crohn’s Disease Market Forecast (2018-2025)
Figure Russia Crohn’s Disease Market Forecast (2018-2025)
Figure Italy Crohn’s Disease Market Forecast (2018-2025)
Figure Rest of Europe Crohn’s Disease Market Forecast (2018-2025)
Figure Asia-Pacific Crohn’s Disease Market Forecast (2018-2025)
Figure China Crohn’s Disease Market Forecast (2018-2025)
Figure Japan Crohn’s Disease Market Forecast (2018-2025)
Figure Korea Crohn’s Disease Market Forecast (2018-2025)
Figure India Crohn’s Disease Market Forecast (2018-2025)
Figure Southeast Asia Crohn’s Disease Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Crohn’s Disease Market Forecast (2018-2025)
Figure South America Crohn’s Disease Market Forecast (2018-2025)
Figure Brazil Crohn’s Disease Market Forecast (2018-2025)
Figure Argentina Crohn’s Disease Market Forecast (2018-2025)
Figure Columbia Crohn’s Disease Market Forecast (2018-2025)
Figure Rest of South America Crohn’s Disease Market Forecast (2018-2025)
Figure Middle East and Africa Crohn’s Disease Market Forecast (2018-2025)
Figure Saudi Arabia Crohn’s Disease Market Forecast (2018-2025)
Figure United Arab Emirates Crohn’s Disease Market Forecast (2018-2025)
Figure Egypt Crohn’s Disease Market Forecast (2018-2025)
Figure Nigeria Crohn’s Disease Market Forecast (2018-2025)
Figure South Africa Crohn’s Disease Market Forecast (2018-2025)
Figure Turkey Crohn’s Disease Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Crohn’s Disease Market Forecast (2018-2025)
Figure Global Crohn’s Disease Forecast by Procedure (2018-2025)
Figure Global Crohn’s Disease Market Share Forecast by Procedure (2018-2025)
Figure Global Crohn’s Disease Forecast by Procedure (2018-2025)
Figure Global Crohn’s Disease Forecast by Drug (2018-2025)
Figure Global Crohn’s Disease Market Share Forecast by Drug (2018-2025)
Figure Global Crohn’s Disease Forecast by Drug (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|